JP2023550466A5 - - Google Patents

Info

Publication number
JP2023550466A5
JP2023550466A5 JP2023530598A JP2023530598A JP2023550466A5 JP 2023550466 A5 JP2023550466 A5 JP 2023550466A5 JP 2023530598 A JP2023530598 A JP 2023530598A JP 2023530598 A JP2023530598 A JP 2023530598A JP 2023550466 A5 JP2023550466 A5 JP 2023550466A5
Authority
JP
Japan
Prior art keywords
methyl
amino
carboxamide
quinoline
dihydrofl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023530598A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023550466A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/060332 external-priority patent/WO2022115377A1/en
Publication of JP2023550466A publication Critical patent/JP2023550466A/ja
Publication of JP2023550466A5 publication Critical patent/JP2023550466A5/ja
Pending legal-status Critical Current

Links

JP2023530598A 2020-11-24 2021-11-22 Prmt5阻害剤としての三環式カルボキサミド誘導体 Pending JP2023550466A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063117937P 2020-11-24 2020-11-24
US63/117,937 2020-11-24
PCT/US2021/060332 WO2022115377A1 (en) 2020-11-24 2021-11-22 Tricyclic carboxamide derivatives as prmt5 inhibitors

Publications (2)

Publication Number Publication Date
JP2023550466A JP2023550466A (ja) 2023-12-01
JP2023550466A5 true JP2023550466A5 (cg-RX-API-DMAC7.html) 2024-11-08

Family

ID=78957958

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023530598A Pending JP2023550466A (ja) 2020-11-24 2021-11-22 Prmt5阻害剤としての三環式カルボキサミド誘導体

Country Status (17)

Country Link
US (1) US20240101570A1 (cg-RX-API-DMAC7.html)
EP (1) EP4251624B1 (cg-RX-API-DMAC7.html)
JP (1) JP2023550466A (cg-RX-API-DMAC7.html)
KR (1) KR20230113339A (cg-RX-API-DMAC7.html)
CN (1) CN116783191A (cg-RX-API-DMAC7.html)
AU (1) AU2021386149A1 (cg-RX-API-DMAC7.html)
CA (1) CA3202141A1 (cg-RX-API-DMAC7.html)
CL (1) CL2023001461A1 (cg-RX-API-DMAC7.html)
CO (1) CO2023007504A2 (cg-RX-API-DMAC7.html)
CR (1) CR20230286A (cg-RX-API-DMAC7.html)
ES (1) ES3058979T3 (cg-RX-API-DMAC7.html)
IL (1) IL302820B2 (cg-RX-API-DMAC7.html)
JO (1) JOP20230113A1 (cg-RX-API-DMAC7.html)
MX (1) MX2023006145A (cg-RX-API-DMAC7.html)
PE (1) PE20231312A1 (cg-RX-API-DMAC7.html)
SA (1) SA523440916B1 (cg-RX-API-DMAC7.html)
WO (1) WO2022115377A1 (cg-RX-API-DMAC7.html)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11077101B1 (en) 2018-07-18 2021-08-03 Tango Therapeutics, Inc. Compounds and methods of use
US12403137B2 (en) 2019-10-28 2025-09-02 Tango Therapeutics, Inc. Compounds and methods of use
CN116568677B (zh) 2020-07-31 2026-07-28 探戈医药股份有限公司 可用于治疗mtap缺乏和/或mta累积癌症的哌啶-1-基-n-吡啶-3-基-2-氧代乙酰胺衍生物
LT4263545T (lt) * 2020-12-16 2026-07-27 Amgen Inc. Prmt5 inhibitoriai
KR20240054299A (ko) * 2021-08-30 2024-04-25 암젠 인크 나프티리딘 유도체 및 이의 중간체의 합성 방법
CN116462677A (zh) * 2022-01-20 2023-07-21 上海和誉生物医药科技有限公司 一种多稠环prmt5抑制剂及其制备方法和应用
CN116462676A (zh) * 2022-01-20 2023-07-21 上海和誉生物医药科技有限公司 一种多稠环prmt5抑制剂及其制备方法和应用
US12552760B2 (en) * 2022-04-22 2026-02-17 The Board Of Trustees Of The University Of Illinois Compounds for increasing the nicotinamide adenine dinucleotide in a subject and methods of use thereof
WO2023246873A1 (zh) * 2022-06-23 2023-12-28 南京明德新药研发有限公司 氨基取代的杂芳基衍生物及其应用
US20250376473A1 (en) * 2022-07-01 2025-12-11 Cytosinlab Therapeutics Co., Ltd. Prmts inhibitor and use thereof
CN117362304A (zh) * 2022-07-07 2024-01-09 深圳微芯生物科技股份有限公司 一种甲酰胺取代的杂三环类衍生物、其制备方法及其应用
WO2024012308A1 (zh) * 2022-07-15 2024-01-18 上海和誉生物医药科技有限公司 一种prmt5抑制剂,其制备方法和在药学上的应用
CA3257212A1 (en) * 2022-08-03 2025-03-19 Abbisko Therapeutics Co., Ltd. Fused three-cycle PRMT5 inhibitor containing nitrogen, its preparation process and its pharmaceutical use
EP4567038A4 (en) * 2022-08-09 2025-12-10 Shanghai Apeiron Therapeutics Company Ltd NEW PRMT5 INHIBITOR AND ITS USE
WO2024038004A1 (en) 2022-08-15 2024-02-22 Astrazeneca Ab Mta-cooperative prmt5 inhibitors for use in the treatment of cancer
CN121405702A (zh) * 2022-09-26 2026-01-27 上海湃隆生物科技有限公司 新型prmt5抑制剂及其应用
EP4638436A1 (en) * 2022-12-22 2025-10-29 Gilead Sciences, Inc. Prmt5 inhibitors and uses thereof
CN120418246A (zh) * 2022-12-23 2025-08-01 成都微芯药业有限公司 一类含炔基取代的杂环酰胺衍生物、其制备方法及其应用
JP2026504889A (ja) * 2023-01-18 2026-02-10 アンテンジーン・ディスカバリー・リミテッド Prmt5阻害化合物およびその使用
WO2024170488A1 (en) 2023-02-13 2024-08-22 Astrazeneca Ab Prmt5 inhibitor for use in cancer therapy
CN120957998A (zh) * 2023-03-30 2025-11-14 百济神州(苏州)生物科技有限公司 作为MTA-协同PRMT5抑制剂的5-氨基-6,8-二氢-1H-呋喃并[3,4-d]吡咯并[3,2-b]吡啶-2-甲酰胺衍生物
PE20260121A1 (es) 2023-04-21 2026-01-16 Gilead Sciences Inc Inhibidores de prmt5 y usos de los mismos
WO2024234821A1 (zh) * 2023-05-17 2024-11-21 四川科伦博泰生物医药股份有限公司 三并环酰胺化合物、包含其的药物组合物及其制备方法和用途
WO2024240894A1 (en) * 2023-05-24 2024-11-28 Ryvu Therapeutics S.A. Prmt5 inhibitors
WO2024245412A1 (en) * 2023-06-02 2024-12-05 Insilico Medicine Ip Limited Prmt5 inhibitors and uses thereof
CN121127465A (zh) 2023-07-14 2025-12-12 江苏亚虹医药科技股份有限公司 蛋白质精氨酸酶甲基转移酶-5抑制剂及其医药用途
CN120865197A (zh) * 2023-08-02 2025-10-31 成都微芯药业有限公司 杂环炔基取代的酰胺衍生物、其制备方法及其应用
WO2025031468A1 (zh) 2023-08-09 2025-02-13 江苏恒瑞医药股份有限公司 杂芳基化合物、其制备方法及其在医药上的应用
CN121127472A (zh) 2023-08-18 2025-12-12 江苏亚虹医药科技股份有限公司 蛋白质精氨酸酶甲基转移酶-5抑制剂及其医药用途
US11858935B1 (en) 2023-09-06 2024-01-02 King Faisal University Pyrrolo[2,3-c][1,7]naphthyridine-2-carboxylic acid compounds as CK2 inhibitors
US11891394B1 (en) 2023-09-06 2024-02-06 King Faisal University Pyrrolo[2,3-c][1,6]naphthyridine-8-carboxylic acid compounds as CK2 inhibitors
WO2025113705A1 (zh) * 2023-12-01 2025-06-05 上海翰森生物医药科技有限公司 N-取代酰胺类衍生物抑制剂、其制备方法和应用
WO2025119326A1 (zh) 2023-12-07 2025-06-12 上海湃隆生物科技有限公司 新型prmt5抑制剂及其应用
US20250230168A1 (en) 2023-12-22 2025-07-17 Gilead Sciences, Inc. Azaspiro wrn inhibitors
WO2025166260A1 (en) * 2024-02-02 2025-08-07 Ideaya Biosciences, Inc. Amide substituted tricyclic guanidino compounds as prmt5 inhibitors
WO2025166257A1 (en) * 2024-02-02 2025-08-07 Ideaya Biosciences, Inc. Amide substituted triheterocyclic guanidino compounds as prmt5 inhibitors
WO2025180517A1 (zh) * 2024-03-01 2025-09-04 武汉人福创新药物研发中心有限公司 含sf5类喹啉衍生物及其作为p2x7拮抗剂的用途
WO2025218671A1 (en) * 2024-04-16 2025-10-23 Shanghai Apeiron Therapeutics Company Limited Novel prmt5 proteolysis targeting chimeric molecules and associated methods of use
US20260130893A1 (en) 2024-10-21 2026-05-14 Gilead Sciences, Inc. Prmt5 inhibitors and uses thereof
CN119552151B (zh) * 2025-01-24 2025-05-02 赛岚(杭州)生物医药科技有限公司 Prmt5抑制剂及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201604022D0 (en) * 2016-03-09 2016-04-20 Ctxt Pty Ltd Compounds
EP4063358B1 (en) * 2016-12-22 2024-05-22 Global Blood Therapeutics, Inc. Histone methyltransferase inhibitors
RS65576B1 (sr) * 2017-11-24 2024-06-28 Jubilant Episcribe Llc Heterociklična jedinjenja kao inhibitori prmt5
WO2019209896A1 (en) * 2018-04-25 2019-10-31 Innate Tumor Immunity, Inc. Nlrp3 modulators

Similar Documents

Publication Publication Date Title
JP7654071B2 (ja) 複素環スピロ化合物及び使用方法
JP7401482B2 (ja) コロニー刺激因子-1受容体(csf-1r)阻害剤
JP7860103B2 (ja) 複素環式スピロ化合物及びその使用方法
JP7576552B2 (ja) イミダゾ[1,2-a]ピリジニル誘導体及び疾患の処置におけるその使用
JP2024532735A (ja) 複素環式化合物及び使用方法
EP4598916A1 (en) Heterocyclic inhibitors of kras g12c mutant proteins and uses thereof
AU2011242778B2 (en) Compounds and methods for kinase modulation, and indications therefor
JP7482116B2 (ja) モノアシルグリセロールリパーゼ調節因子
AU2021386149A1 (en) Tricyclic carboxamide derivatives as prmt5 inhibitors
US11993601B2 (en) Monoacylglycerol lipase modulators
JP2012528828A5 (cg-RX-API-DMAC7.html)
JP6847954B2 (ja) キナーゼ阻害剤としての三環式化合物および組成物
WO2025194057A1 (en) Macrocyclic compounds as modulators of kras and uses thereof
CN111868037A (zh) 作为crhr2拮抗剂的稠合环状脲衍生物
WO2025230878A1 (en) Macrocyclic compounds as modulators of kras and uses thereof
WO2025017078A1 (en) New pyrazolopyridine derivatives
TW202412783A (zh) 酪胺酸激酶2抑制劑及其用途
CA3258960A1 (en) CSF-1R INHIBITORS AND THEIR USES
CN117897159A (zh) 杂环化合物及使用方法
HK40058344A (zh) 单酰基甘油脂肪酶调节剂